EMF biological effects
Share

[Experience with turbulent magnetic field as a component of breast cancer therapy].

V P Letiagin, N V Protchenko, Iu L Rybakov, Ia V Dobrynin

PAPERpubmedVoprosy onkologii2003randomized trialEffect: benefitEvidence: Low

Abstract

No adverse side-effects were reported in an investigation of the antitumor effect of turbulent magnetic field (TMF) carried out as a component of preoperative chemoradiotherapy for breast cancer at the Center's Clinic. The study group included 114 patients with locally advanced tumors(T3, N1-N3, M0). According to the clinical, roentgenological and histological evidence on the end-results, the procedure was highly effective. Also, it was followed by shorter and less extensive postoperative lymphorrhea.

AI evidence extraction

At a glance
Study type
randomized trial
Effect direction
benefit
Population
Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy
Sample size
114
Exposure
turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy
Evidence strength
Low
Confidence: 66% · Peer-reviewed: yes

Main findings

In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.

Outcomes measured

  • Antitumor effect / treatment effectiveness (clinical
  • roentgenological
  • histological end-results)
  • Adverse side-effects
  • Postoperative lymphorrhea duration and extent

Limitations

  • Randomization not described in the abstract despite the publication type listing 'Clinical Trial'
  • No exposure parameters reported (e.g.
  • field strength
  • frequency
  • duration)
  • No comparator/control group described
  • Outcomes are described qualitatively without effect sizes or statistical details
View raw extracted JSON
{
  "study_type": "randomized_trial",
  "exposure": {
    "band": null,
    "source": "turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy",
  "sample_size": 114,
  "outcomes": [
    "Antitumor effect / treatment effectiveness (clinical, roentgenological, histological end-results)",
    "Adverse side-effects",
    "Postoperative lymphorrhea duration and extent"
  ],
  "main_findings": "In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.",
  "effect_direction": "benefit",
  "limitations": [
    "Randomization not described in the abstract despite the publication type listing 'Clinical Trial'",
    "No exposure parameters reported (e.g., field strength, frequency, duration)",
    "No comparator/control group described",
    "Outcomes are described qualitatively without effect sizes or statistical details"
  ],
  "evidence_strength": "low",
  "confidence": 0.66,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "turbulent magnetic field",
    "TMF",
    "breast cancer",
    "preoperative chemoradiotherapy",
    "clinical trial",
    "lymphorrhea"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 3716

[Experience with turbulent magnetic field as a component of breast cancer therapy]. · Non-native EMF